curacle co., ltd.
A clinical-stage biopharma developing drugs for intractable vascular diseases.
365270 | KO
Overview
Corporate Details
- ISIN(s):
- KR7365270008
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 서초구 효령로 23-1, 서울특별시
- Website:
- http://www.curacle.com/eng/main/
Description
Curacle Co., Ltd. is a clinical-stage biopharmaceutical company focused on the research and development of innovative drugs for intractable vascular diseases. The company's core platform technology centers on developing highly effective protectors against endothelial dysfunction, a key factor in various age-related and vascular conditions. Its development pipeline includes novel treatments targeting significant unmet medical needs, with a particular focus on conditions such as Diabetic Macular Edema (DME), Wet Age-related Macular Degeneration (wet AMD), diabetes, and stroke. Curacle aims to create differentiated therapies through innovative targets and treatment concepts, including the development of orally administered medications for complex eye diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-16 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.3 KB | ||
| 2025-09-12 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 26.1 KB | ||
| 2025-09-12 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 26.3 KB | ||
| 2025-09-12 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.2 KB | ||
| 2025-09-12 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 101.4 KB | ||
| 2025-09-09 00:00 |
증권발행실적보고서
|
Korean | 113.1 KB | ||
| 2025-09-09 00:00 |
증권발행결과(자율공시) (주주배정후 실권주 일반공모)
|
Korean | 8.1 KB | ||
| 2025-09-09 00:00 |
[기재정정]증권발행실적보고서
|
Korean | 121.2 KB | ||
| 2025-09-08 00:00 |
유상증자또는주식관련사채등의청약결과(자율공시) (주주배정후 실권주 일반공모)
|
Korean | 10.3 KB | ||
| 2025-09-03 00:00 |
유상증자또는주식관련사채등의청약결과(자율공시) (주주배정후 실권주 일반공모)
|
Korean | 9.7 KB | ||
| 2025-08-28 00:00 |
유상증자최종발행가액확정
|
Korean | 11.4 KB | ||
| 2025-08-28 00:00 |
[기재정정]주요사항보고서(유상증자결정)
|
Korean | 41.6 KB | ||
| 2025-08-28 00:00 |
[발행조건확정]증권신고서(지분증권)
|
Korean | 260.5 KB | ||
| 2025-08-28 00:00 |
[기재정정]투자설명서
|
Korean | 2.2 MB | ||
| 2025-08-13 00:00 |
[기재정정]증권신고서(지분증권) (2025.08)
|
Korean | 2.4 MB |
Automate Your Workflow. Get a real-time feed of all curacle co., ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for curacle co., ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for curacle co., ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
